Mental Health Navigation for Youth Mental Health

(FMHN Trial)

Overseen by Marina Tolou-Shams, Ph.D

Age: < 18

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: University of California, San Francisco

No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial tests a support system called the Family Mental Health Navigator (FMHN) combined with mobile technology to help publicly-insured youth access mental health services. It aims to improve how these young people start and stay in treatment, especially those from racial and ethnic minority groups.

Research Team

Marina Tolou-Shams, Ph.D

Principal Investigator

University of California, San Francisco

Eligibility Criteria

This trial is for English or Spanish-speaking children aged 6-17 who are publicly insured and currently receiving services at San Francisco General Hospital. They must have mobile phone access and an involved caregiver to provide consent. Children without a guardian's consent, non-English/Spanish speakers, or caregivers unable to give informed consent cannot participate.

Inclusion Criteria

I speak English or Spanish.

Are currently receiving services at the San Francisco General Hospital

Are publicly insured

Exclusion Criteria

Caregiver has impairment that would preclude providing informed consent

I do not speak English or Spanish.

Unavailable guardian for consent

Treatment Details

Interventions

• Family-based mental health navigation (Behavioral Intervention)
• Standard of care engagement practices (Behavioral Intervention)

Trial Overview The study is testing a new approach called the Family Mental Health Navigator (FMHN), which uses family-based guidance along with mobile health technology to see if it helps young people start and stick with mental health services more effectively.

Participant Groups

Group I: Family-based mental health navigation Experimental Treatment 1 Intervention

Family-based navigator intervention combined with mHealth practices to improve mental health treatment initiation and engagement

Who Is Running the Clinical Trial?

University of California, San Francisco

Lead Sponsor

Trials

2,636

Recruited

19,080,000+

Suresh Gunasekaran

University of California, San Francisco

Chief Executive Officer since 2022

MBA from Southern Methodist University

Dr. Lukejohn Day

University of California, San Francisco

Chief Medical Officer

MD from Stanford University School of Medicine

San Francisco General Hospital Foundation

Collaborator

Trials

1

Recruited

150+